Skip to main content
Clinical Trials/NCT06241547
NCT06241547
Active, Not Recruiting
Phase 2

Perioperative Percutaneous Electrical Nerve Stimulation Via a Wearable Equipment on Postoperative Nausea and Vomiting(PONV) in Patients Undergoing Laparoscopy Abdominal Surgery: a Prospective Randomized Controlled Trial

Peking Union Medical College Hospital1 site in 1 country302 target enrollmentJanuary 12, 2024

Overview

Phase
Phase 2
Intervention
electrical stimualtion via EmeTerm bracelet
Conditions
Postoperative Nausea and Vomiting
Sponsor
Peking Union Medical College Hospital
Enrollment
302
Locations
1
Primary Endpoint
Incidence of postoperative nausea and vomiting(PONV)
Status
Active, Not Recruiting
Last Updated
19 days ago

Overview

Brief Summary

This study aims to certify the effectiveness of percutaneous electrical nerve stimulation at Pericardium 6 (PC6) via a wearable equipment during perioperative period on preventing postoperative nausea and vomiting.

Detailed Description

Introduction: This study aims to certify the effectiveness of percutaneous electrical nerve stimulation at Pericardium 6 (PC6) via a wearable equipment during perioperative period on preventing postoperative nausea and vomiting. Method and analysis: A total of approximately 302 patients undergoing elective laparoscopic surgery will be enrolled. Participants will be randomly assigned to either a electrical stimulation group or a placebo group, with computer-generated randomization and concealed allocation using sealed envelopes. The electrical stimulation group will receive PC point electrical stimulation 30 minutes before surgery until 24 hours postoperatively, while the placebo group will wear a wristband without stimulation. The primary outcome will be the incidence of postoperative nausea and vomiting, with secondary outcomes including the incidence of nausea and vomiting within 24 hours after surgery, gastrointestinal and hemodynamic indices, postoperative recovery, hospital stay and cost, and complications.

Registry
clinicaltrials.gov
Start Date
January 12, 2024
End Date
March 30, 2026
Last Updated
19 days ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients aged 18-65 years;
  • Patients undergoing elective laparoscopic surgery;
  • American Society of Anaesthesiologists(ASA) Grade 1 to 3;
  • Anesthesia: General Anesthesia, Tracheal Intubation;
  • BMI: ≥18, \<28;
  • Gender: female
  • Patients or their family members are able to comprehend the study protocol and are willing to participate in this research by providing written informed consent.

Exclusion Criteria

  • There are incisions or scars in the wearing position of the device;
  • There is a local infection in the wearing position of the device;
  • upper extremity nerve injury;
  • history of spinal cord surgery;
  • Participated in other clinical trials within 4 weeks;
  • suffering from severe central nervous system disease or mental disorder;
  • Patients need to return to the ICU after surgery.

Arms & Interventions

stimulation group

accept general drug prevention, wear the equipment, and receive electrical stimulation.

Intervention: electrical stimualtion via EmeTerm bracelet

stimulation group

accept general drug prevention, wear the equipment, and receive electrical stimulation.

Intervention: antimetic drugs( dexamethasone,ondansetron)

control group

accept general drug prevention and wear the equipment but receive no electrical stimulation

Intervention: antimetic drugs( dexamethasone,ondansetron)

Outcomes

Primary Outcomes

Incidence of postoperative nausea and vomiting(PONV)

Time Frame: 24 hours after surgery

Ask patients if they experienced nausea or vomiting 24 hours after surgery.

Study Sites (1)

Loading locations...

Similar Trials